|Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire|
K Hueniken, CM Douglas, AR Jethwa, M Mirshams, L Eng, A Hope, ...
Cancer 126 (17), 4042-4050, 2020
|Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programming|
R Aggarwal, K Hueniken, L Eng, S Kassirian, I Geist, K Balaratnam, ...
Supportive Care in Cancer 28, 4789-4801, 2020
|Effect of high-dose vitamin D supplementation on upper respiratory tract infection symptom severity in healthy children|
K Hueniken, M Aglipay, CS Birken, PC Parkin, MB Loeb, KE Thorpe, ...
The Pediatric Infectious Disease Journal 38 (6), 564-568, 2019
|Internet and social media use in cancer patients: association with distress and perceived benefits and limitations|
JL Bender, K Hueniken, L Eng, MC Brown, S Kassirian, I Geist, ...
Supportive Care in Cancer 29, 5273-5281, 2021
|Age differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors|
L Eng, J Bender, K Hueniken, S Kassirian, L Mitchell, R Aggarwal, ...
Journal of Geriatric Oncology 11 (6), 1011-1019, 2020
|Cancer patient-reported preferences and knowledge for liquid biopsies and blood biomarkers at a comprehensive cancer center|
MJ Lee, K Hueniken, N Kuehne, L Lu, SX Jiang, B Id Said, A McCartney, ...
Cancer Management and Research, 1163-1173, 2020
|Real‐world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non‐small cell lung cancer|
SX Jiang, RN Walton, K Hueniken, J Baek, A McCartney, C Labbé, ...
Cancer medicine 8 (18), 7542-7555, 2019
|A comparison of hypofractionated and twice-daily thoracic irradiation in limited-stage small-cell lung cancer: an overlap-weighted analysis|
M Yan, S Sigurdson, N Greifer, TAC Kennedy, TS Toh, PE Lindsay, ...
Cancers 13 (12), 2895, 2021
|Outcomes of long-term interval rescreening with low-dose computed tomography for lung cancer in different risk cohorts|
R Aggarwal, ACL Lam, M McGregor, R Menezes, K Hueniken, H Tateishi, ...
Journal of Thoracic Oncology 14 (6), 1003-1011, 2019
|Out‐of‐pocket costs associated with head and neck cancer treatment|
MN Khan, K Hueniken, M Manojlovic‐Kolarski, L Eng, M Mirshams, ...
Cancer Reports 5 (7), e1528, 2022
|Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis|
SWS Chan, E Smith, R Aggarwal, K Balaratnam, RQ Chen, K Hueniken, ...
Clinical Lung Cancer 22 (5), 390-407, 2021
|Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre|
M Yan, TS Toh, PE Lindsay, J Weiss, K Hueniken, C Yeung, V Sugumar, ...
Clinical and Translational Radiation Oncology 30, 43-49, 2021
|Real-world treatment sequencing, toxicities, health utilities, and survival outcomes in patients with advanced ALK-rearranged non-small-cell lung cancer|
S Schmid, S Cheng, S Chotai, M Garcia, L Zhan, K Hueniken, ...
Clinical lung cancer 24 (1), 40-50, 2023
|Longitudinal health utility and symptom‐toxicity trajectories in patients with head and neck cancers|
J Ren, W Pang, K Hueniken, G Haddad, A Hope, SH Huang, A Spreafico, ...
Cancer 128 (3), 497-508, 2022
|Psychometric testing of the Skull Base Inventory health-related quality of life questionnaire in a multi-institutional study of patients undergoing open and endoscopic surgery|
D Forner, K Hueniken, T Yoannidis, I Witterick, E Monteiro, G Zadeh, ...
Quality of Life Research 30, 293-301, 2021
|Association of Household Income at Diagnosis With Financial Toxicity, Health Utility, and Survival in Patients With Head and Neck Cancer|
CW Noel, K Hueniken, D Forner, G Liu, L Eng, A Hosni, E Hahn, JC Irish, ...
JAMA Otolaryngology–Head & Neck Surgery 149 (1), 63-70, 2023
|EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada|
MS Kuruvilla, G Liu, I Syed, F Gwadry-Sridhar, BS Sheffield, R Sachdeva, ...
Lung Cancer 173, 58-66, 2022
|Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-) radiotherapy delivered under similar …|
S Gudi, B O'Sullivan, A Hosni, J Su, A Hope, J Ringash, K Hueniken, ...
Oral Oncology 120, 105419, 2021
|Longitudinal health utilities, symptoms and toxicities in patients with ALK-rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment|
BC Tse, BI Said, ZJ Fan, K Hueniken, D Patel, G Gill, M Liang, M Razooqi, ...
Current Oncology 27 (6), 552-559, 2020
|P48. 05 is relapse-free survival at 2-years an appropriate surrogate for overall survival at 5-years in EGFR-mutated resected NSCLC?|
M Garcia, S Schmid, K Hueniken, L Zhan, K Balaratnam, K Khan, A Fares, ...
Journal of Thoracic Oncology 16 (10), S1107-S1108, 2021